IGHE and asthma: Pharmacologic management of asthma typically involves inhaled corticosteroids (ICS), β2-adrenergic agonists, leukotriene receptor antagonists, anticholinergic agents, and targeted biologic therapies such as monoclonal antibodies against IL-5, IL-4Rα, and IgE.